mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival

Carla Garza-Lombó, Annika Schroder, Elsa M. Reyes-Reyes, Rodrigo Franco-Cruz

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

The mechanistic (or mammalian) target of rapamycin (mTOR) and the adenosine monophosphate-activated protein kinase (AMPK) regulate cell survival and metabolism in response to diverse stimuli such as variations in amino acid content, changes in cellular bioenergetics, oxygen levels, neurotrophic factors and xenobiotics. This Opinion paper aims to discuss the current state of knowledge regarding how mTOR and AMPK regulate the metabolism and survival of brain cells and the close interrelationship between both signaling cascades. It is now clear that both mTOR and AMPK pathways regulate cellular homeostasis at multiple levels. Studies so far demonstrate that dysregulation in these two pathways is associated with neuronal injury, degeneration and neurotoxicity, but the mechanisms involved remain unclear. Most of the work so far has been focused on their antagonistic regulation of autophagy, but recent findings highlight that changes in protein synthesis, metabolism and mitochondrial function are likely to play a role in the regulatory effects of both mTOR and AMPK on neuronal health. Understanding their role and relationship between these two master regulators of cell metabolism is crucial for future therapeutic approaches to counteract alterations in cell metabolism and survival in brain injury and disease.

Original languageEnglish (US)
Pages (from-to)102-110
Number of pages9
JournalCurrent Opinion in Toxicology
Volume8
DOIs
StatePublished - Apr 2018

Fingerprint

Sirolimus
Adenosine Monophosphate
Metabolism
Protein Kinases
Brain
Cell Survival
Autophagy
Nerve Growth Factors
Brain Diseases
Xenobiotics
Brain Injuries
Energy Metabolism
Homeostasis
Cells
Health
Oxygen
Amino Acids
Wounds and Injuries
Proteins

Keywords

  • Adenosine monophosphate-activated protein kinase
  • Autophagy
  • Cell death
  • Energy failure
  • Glycolysis
  • Mammalian target of rapamycin
  • Mitochondria
  • Nutrient deprivation

ASJC Scopus subject areas

  • Toxicology

Cite this

mTOR/AMPK signaling in the brain : Cell metabolism, proteostasis and survival. / Garza-Lombó, Carla; Schroder, Annika; Reyes-Reyes, Elsa M.; Franco-Cruz, Rodrigo.

In: Current Opinion in Toxicology, Vol. 8, 04.2018, p. 102-110.

Research output: Contribution to journalReview article

Garza-Lombó, Carla ; Schroder, Annika ; Reyes-Reyes, Elsa M. ; Franco-Cruz, Rodrigo. / mTOR/AMPK signaling in the brain : Cell metabolism, proteostasis and survival. In: Current Opinion in Toxicology. 2018 ; Vol. 8. pp. 102-110.
@article{8fa87f66b2a84059829d7ced29aa004f,
title = "mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival",
abstract = "The mechanistic (or mammalian) target of rapamycin (mTOR) and the adenosine monophosphate-activated protein kinase (AMPK) regulate cell survival and metabolism in response to diverse stimuli such as variations in amino acid content, changes in cellular bioenergetics, oxygen levels, neurotrophic factors and xenobiotics. This Opinion paper aims to discuss the current state of knowledge regarding how mTOR and AMPK regulate the metabolism and survival of brain cells and the close interrelationship between both signaling cascades. It is now clear that both mTOR and AMPK pathways regulate cellular homeostasis at multiple levels. Studies so far demonstrate that dysregulation in these two pathways is associated with neuronal injury, degeneration and neurotoxicity, but the mechanisms involved remain unclear. Most of the work so far has been focused on their antagonistic regulation of autophagy, but recent findings highlight that changes in protein synthesis, metabolism and mitochondrial function are likely to play a role in the regulatory effects of both mTOR and AMPK on neuronal health. Understanding their role and relationship between these two master regulators of cell metabolism is crucial for future therapeutic approaches to counteract alterations in cell metabolism and survival in brain injury and disease.",
keywords = "Adenosine monophosphate-activated protein kinase, Autophagy, Cell death, Energy failure, Glycolysis, Mammalian target of rapamycin, Mitochondria, Nutrient deprivation",
author = "Carla Garza-Lomb{\'o} and Annika Schroder and Reyes-Reyes, {Elsa M.} and Rodrigo Franco-Cruz",
year = "2018",
month = "4",
doi = "10.1016/j.cotox.2018.05.002",
language = "English (US)",
volume = "8",
pages = "102--110",
journal = "Current Opinion in Toxicology",
issn = "2468-2020",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - mTOR/AMPK signaling in the brain

T2 - Cell metabolism, proteostasis and survival

AU - Garza-Lombó, Carla

AU - Schroder, Annika

AU - Reyes-Reyes, Elsa M.

AU - Franco-Cruz, Rodrigo

PY - 2018/4

Y1 - 2018/4

N2 - The mechanistic (or mammalian) target of rapamycin (mTOR) and the adenosine monophosphate-activated protein kinase (AMPK) regulate cell survival and metabolism in response to diverse stimuli such as variations in amino acid content, changes in cellular bioenergetics, oxygen levels, neurotrophic factors and xenobiotics. This Opinion paper aims to discuss the current state of knowledge regarding how mTOR and AMPK regulate the metabolism and survival of brain cells and the close interrelationship between both signaling cascades. It is now clear that both mTOR and AMPK pathways regulate cellular homeostasis at multiple levels. Studies so far demonstrate that dysregulation in these two pathways is associated with neuronal injury, degeneration and neurotoxicity, but the mechanisms involved remain unclear. Most of the work so far has been focused on their antagonistic regulation of autophagy, but recent findings highlight that changes in protein synthesis, metabolism and mitochondrial function are likely to play a role in the regulatory effects of both mTOR and AMPK on neuronal health. Understanding their role and relationship between these two master regulators of cell metabolism is crucial for future therapeutic approaches to counteract alterations in cell metabolism and survival in brain injury and disease.

AB - The mechanistic (or mammalian) target of rapamycin (mTOR) and the adenosine monophosphate-activated protein kinase (AMPK) regulate cell survival and metabolism in response to diverse stimuli such as variations in amino acid content, changes in cellular bioenergetics, oxygen levels, neurotrophic factors and xenobiotics. This Opinion paper aims to discuss the current state of knowledge regarding how mTOR and AMPK regulate the metabolism and survival of brain cells and the close interrelationship between both signaling cascades. It is now clear that both mTOR and AMPK pathways regulate cellular homeostasis at multiple levels. Studies so far demonstrate that dysregulation in these two pathways is associated with neuronal injury, degeneration and neurotoxicity, but the mechanisms involved remain unclear. Most of the work so far has been focused on their antagonistic regulation of autophagy, but recent findings highlight that changes in protein synthesis, metabolism and mitochondrial function are likely to play a role in the regulatory effects of both mTOR and AMPK on neuronal health. Understanding their role and relationship between these two master regulators of cell metabolism is crucial for future therapeutic approaches to counteract alterations in cell metabolism and survival in brain injury and disease.

KW - Adenosine monophosphate-activated protein kinase

KW - Autophagy

KW - Cell death

KW - Energy failure

KW - Glycolysis

KW - Mammalian target of rapamycin

KW - Mitochondria

KW - Nutrient deprivation

UR - http://www.scopus.com/inward/record.url?scp=85048471592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048471592&partnerID=8YFLogxK

U2 - 10.1016/j.cotox.2018.05.002

DO - 10.1016/j.cotox.2018.05.002

M3 - Review article

C2 - 30417160

AN - SCOPUS:85048471592

VL - 8

SP - 102

EP - 110

JO - Current Opinion in Toxicology

JF - Current Opinion in Toxicology

SN - 2468-2020

ER -